Cargando…

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy

Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, causes adult T-cell leukemia-lymphoma, HTLV-1 associated myelopathy/tropical spastic paraparesis, and HTLV-1 uveitis. Currently, no antiretroviral therapies or vaccines are available for HTLV-1 infection. This study aimed to develop an antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatayama, Yasuyoshi, Yamaoka, Yutaro, Morita, Takeshi, Jeremiah, Sundararaj Stanleyraj, Miyakawa, Kei, Nishi, Mayuko, Kimura, Yayoi, Mitsunaga, Makoto, Iwase, Tadayuki, Kimura, Hirokazu, Yamamoto, Naoki, Takaori-Kondo, Akifumi, Hasegawa, Hideki, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608601/ https://www.ncbi.nlm.nih.gov/pubmed/36298708 http://dx.doi.org/10.3390/v14102153

Ejemplares similares

Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2
por: Ino, Yoko, et al.
Publicado: (2022)

Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
por: Nakai, Yusuke, et al.
Publicado: (2022)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2022)

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2
por: Miyakawa, Kei, et al.
Publicado: (2022)

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
por: Yamaoka, Yutaro, et al.
Publicado: (2022)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor
por: Funabashi, Rikako, et al.
Publicado: (2021)

Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
por: Goto, Keiko, et al.
Publicado: (2020)

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Prospective Clinical Evaluation of the Diagnostic Accuracy of a Highly Sensitive Rapid Antigen Test Using Silver Amplification Technology for Emerging SARS-CoV-2 Variants
por: Obata, Kazuaki, et al.
Publicado: (2022)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests
por: Yamaoka, Yutaro, et al.
Publicado: (2021)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein
por: Kimura, Yayoi, et al.
Publicado: (2022)

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors
por: Goto, Atsushi, et al.
Publicado: (2021)

Antimicrobial strategy for targeted elimination of different microbes, including bacterial, fungal and viral pathogens
por: Mitsunaga, Makoto, et al.
Publicado: (2022)

NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
por: Bano, Shazia, et al.
Publicado: (2020)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
por: Miyakawa, Kei, et al.
Publicado: (2019)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
por: Miyakawa, Kei, et al.
Publicado: (2022)

Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice
por: Nagata, Kayoko, et al.
Publicado: (2022)

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
por: Kimura, Yayoi, et al.
Publicado: (2021)

Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals
por: Mota-Miranda, Aline C A, et al.
Publicado: (2013)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

The tumour suppressor APC promotes HIV-1 assembly via interaction with Gag precursor protein
por: Miyakawa, Kei, et al.
Publicado: (2017)

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins
por: Miyakawa, Kei, et al.
Publicado: (2022)

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction
por: Miyakawa, Kei, et al.
Publicado: (2015)

Stability of the HTLV-1 glycoprotein 46 (gp46) gene in an endemic region of the Brazilian Amazon and the presence of a significant mutation (N93D) in symptomatic patients
por: Socorro de Almeida Viana, Maria de Nazaré do, et al.
Publicado: (2018)

Genetic diversity in HTLV-1 envelope (gp46), HBZ And LTR region from assymptomatic And TSP/HAM individuals
por: Mota-Miranda, Aline C A, et al.
Publicado: (2011)

A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron
por: Maeda, Ryota, et al.
Publicado: (2022)

Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46
por: Saito, Mineki, et al.
Publicado: (2014)

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell
por: Nishi, Mayuko, et al.
Publicado: (2014)

Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160
por: Yoshizaki, Shinji, et al.
Publicado: (2011)

Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen
por: Yamaoka, Yutaro, et al.
Publicado: (2016)

Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19
por: Saji, Ryo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_heq83qu5oedip4oiml277hter7